Pharmacoepidemiology and Drug Safety in Pregnancy and Breastfeeding
A special issue of Pharmacoepidemiology (ISSN 2813-0618).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 8250
Special Issue Editors
2. Laboratory of Healthcare Research & Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy
Interests: population-based birth cohort study; pharmacoepidemiology and drug safety in pregnancy and breastfeeding; pharmacoepidemiology; healthcare research; real-world data
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacoepidemiology; healthcare research; real-world data; population-based birth cohort study; utilization, comparative safety and effectiveness of prescription medications in pregnant women and their offsprin
Interests: population-based birth cohort study; longitudinal studies; environmental epidemiology; pharmacoepidemiology; real-world data
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Maternal and child health represents a fundamental component of public health, not only because pregnancy, childbirth, and the puerperium are the first cause of hospitalization, but also because the events “around” birth are used as indicators for assessing the quality of healthcare.
The World Health Organization stresses the importance of directing more resources to evaluate maternal and child health in order to (i) implement preventive interventions during pregnancy, childbirth, and the first years of the child's life, thus preventing avoidable deaths; and (ii) make qualified assistance and appropriate drug treatments more accessible.
Indeed, prescribing medications to pregnant or breastfeeding women is usually challenging as the drug benefit must be considered against its potential adverse effects to both mother and child. Medication use is common in pregnant or breastfeeding women, by chance or necessity, and it gives the opportunity to evaluate the consequences of prenatal drug exposure in real life through pharmacoepidemiologic studies.
Given the complexity of the set of issues and problems relating to the birth path and maternal–infant health, this Special Issue aims to investigate pharmacoepidemiology and drug safety in pregnancy or breastfeeding. Focus is also given to the methodological challenges related to assessing medication safety and effectiveness in the context of real-world pregnancy and breastfeeding research.
Dr. Anna Cantarutti
Dr. Angela Lupattelli
Dr. Cristina Canova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacoepidemiology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- population-based birth cohort study
- pharmacoepidemiology and drug safety in pregnancy and breastfeeding
- pharmacoepidemiology
- healthcare research
- real-world data
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.